Associations between methadone maintenance treatment and crime: a 17‐year longitudinal cohort study of Canadian provincial offenders

Russolillo, Angela; Moniruzzaman, Akm; McCandless, Lawrence C.; Patterson, Michelle; Somers, Julian M.

doi:10.1111/add.14059

Cited by 49 publications

(45 citation statements)

References 53 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Whereas some research assumes a correlation between impaired impulse control and criminal behavior [19, 73-75], we did not find any relation between BIS-11 scores and the number of convictions or months of imprisonment. Other studies suggest a decrease in crime rates as a result of the methadone maintenance program itself [76]. Hepatitis as result of needle-sharing can be considered another “real-life” indicator for impulsivity.…”

Section: Discussionmentioning

confidence: 99%

Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy

Peters

Soyka

2018

Neuropsychobiology

View full text Add to dashboard Cite

Objective: A growing number of studies indicate increased impulsivity in patients with opioid dependence (OD). However, few studies exclude concomitant drug use and consider depression as a comorbidity, both of which can bias results. Aim: We aimed to compare impulsivity in patients with OD enrolled in maintenance therapy (ICD code F11.22) and well-matched healthy controls taking psychopathological impairments into account. Furthermore, we compared the result to risky behavioral patterns in patients. Methods: This cross-sectional study included 50 patients with OD enrolled in either methadone or buprenorphine maintenance therapy and 50 healthy controls matched for gender, age, education, marital status, and premorbid intelligence. Abstinence from benzodiazepines, amphetamines, and cocaine was verified by urine analysis. We used the Barratt Impulsiveness Scale 11 (BIS-11), Beck’s Depression Inventory (BDI), the Symptom Checklist 90 Revised (SCL-90R), and the European version of the Addiction Severity Index (EuropASI). Results: Patients exhibited significantly worse impulse control than healthy individuals. We found no correlation between impulsiveness and reported risky behavior patterns but found a significant correlation between depressive symptoms and psychopathological impairment. Conclusions: Patients with OD showed a higher impulsivity than healthy individuals. Impulsivity could be a cause or a consequence of a substance use disorder; further research is warranted to explain this relationship. Impulsivity was associated with depression, an important confounder; future research needs to take this into account.

show abstract

Section: Discussionmentioning

confidence: 99%

Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy

Peters

Soyka

2018

Neuropsychobiology

View full text Add to dashboard Cite

show abstract

“…Observational studies have consistently reported OST to be associated with suppression of illicit opioid use (e.g. Hubbard et al, 2003;Mattick et al, 2014Mattick et al, , 2009Simpson et al, 1982;Teesson et al, 2006), a lower risk of opioid overdose (White et al, 2015), and reductions in crime (Russolillo et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

Change in alcohol and other drug use during five years of continuous opioid substitution treatment

Eastwood

Strang

Marsden

2019

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…Moreover, OMTs improve the overall functioning of opioid dependence patients [22,24,25], and have thus allowed improving the recovery trajectory of many opioid users. At a societal level, methadone and buprenorphine have even been shown to lower the rate of crimes committed by subjects with opioid dependence [26]. Methadone and buprenorphine have also demonstrated a good cost-effectiveness ratio in the context of developed countries [27,28].…”

Section: Current Best Treatments For Opioid Dependencementioning

confidence: 99%

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

Vorspan

Hjelmström

Simon

et al. 2019

Expert Opinion on Drug Delivery

View full text Add to dashboard Cite

Introduction: Since the 1990s, opioid maintenance treatments (OMTs), i.e. mostly methadone and buprenorphine, have represented the therapeutic cornerstone of opioid dependence. In France, the public health strategy on opioid dependence, identified here as the 'French model', has consisted of offering a facilitated access to buprenorphine, to reach a large treatment coverage and reduce opioidrelated mortality. Areas covered: Recently, a new formulation of subcutaneous buprenorphine depot (Buvidal®) has been approved in Europe for treatment of opioid dependence. The place of Buvidal® among the pre-existing arsenal of OMTs is discussed in the light of the pharmacological specificities of this new formulation, and with the particular standpoint of the French model on opioid dependence. Expert opinion: Buvidal® could constitute a promising treatment option mainly in case of: 1) OMT initiation, including in non-specialized addiction medicine care; 2) Discharge from prison or hospital; Diversion/misuse of 3) buprenorphine or 4) methadone; 5) Clinically stabilized patients wishing to avoid daily oral taking of the medication. As such, this new formulation should be highly accessible, which will require specific pathways through care as the product is intended to be administered by a healthcare professional.

show abstract

Associations between methadone maintenance treatment and crime: a 17‐year longitudinal cohort study of Canadian provincial offenders

Abstract: Among a cohort of Canadian offenders, rates of violent and non-violent offending were lower during periods when individuals were dispensed methadone compared with periods in which they were not dispensed methadone.

Cited by 49 publications

References 53 publications

Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy

Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy

Change in alcohol and other drug use during five years of continuous opioid substitution treatment

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine

Contact Info

Product

Resources

About